Intrapreneurial Practices of Selected Global Pharmaceutical Companies: An Analysis
| dc.contributor.author | Angrish, Anil Kumar | |
| dc.contributor.author | Reddy, Prathyusha | |
| dc.contributor.author | Aggarwal, Vikas | |
| dc.contributor.author | Sharma, Anand | |
| dc.date.accessioned | 2021-03-08T08:11:15Z | |
| dc.date.available | 2021-03-08T08:11:15Z | |
| dc.date.issued | 2021-02-25 | |
| dc.description | Fourteenth Biennial Conference on Entrepreneurship/ Edited by Rajeev Sharma, Sunil Shukla, Amit Kumar Dwivedi & Ganapathi Batthini | en_US |
| dc.description.abstract | Intrapreneurship is recognized as an act of entrepreneurship within an organization. Organizations employ skills and spirits of an entrepreneur, among their employees. Globally, MNCs have realized that to grow further, they have to acquire a start-up mindset and zeal of an entrepreneur and for this; they have to nurture ‘intrapreneurs’. In this paper, intrapreneurial practices of selected global pharmaceutical companies have been identified. Besides identification, i.e., covering ‘what’ aspect, their geographic presence, an emphasis is to identify ‘how they do’, i.e., ‘how’ aspect of intrapreneurship. Twenty (20) out of top fifty (50) global pharmaceutical companies as recognized in terms of their revenue have been selected for further analysis. It has been observed that the concept of intrapreneurship is being applied in diverse areas within pharmaceutical industry, i.e., in Research and Development (R&D), Product Development, exploring new markets, contribution towards communities including application in Corporate Social Responsibility (CSR) activities, among others. | en_US |
| dc.identifier.isbn | 9789386578587 | |
| dc.identifier.uri | https://dspace.ediindia.ac.in/handle/123456789/12659 | |
| dc.language.iso | en | en_US |
| dc.publisher | Bookwell Delhi | en_US |
| dc.subject | intrapreneur | en_US |
| dc.subject | intrapreneurship | en_US |
| dc.subject | pharmaceutical companies | en_US |
| dc.title | Intrapreneurial Practices of Selected Global Pharmaceutical Companies: An Analysis | en_US |
| dc.type | Article | en_US |
